PRIVATE PATENTS AND PUBLIC HEALTH

More documents

Recommendations

Info

PRIVATE PATENTS AND PUBLIC HEALTH CHANGING INTELLECTUAL PROPERTY RULES FOR ACCESS TO MEDICINES
PRIVATE PATENTS AND PUBLIC HEALTH PRIVATE PATENTS AND PUBLIC HEALTH CHANGING INTELLECTUAL PROPERTY RULES FOR ACCESS TO MEDICINES PUBLISHED BY Health Action International Overtoom 60 (2) 1054 HK Amsterdam The Netherlands www.haiweb.org Copyright © 2016 Ellen ’t Hoen The author has made an online version of this work available under a Creative Commons Attribution-Noncommercial-ShareAlike 3.0 licence. The eBook can be accessed at www.accesstomedicines.org ISBN 978-90-74006-00-2 Cover photo: © Marlene Ford | Dreamstime.com
Page 1: “Ellen ’t Hoen is a towering fi
Page 5 and 6: ACKNOWLEDGEMENTS PRIVATE PATENTS AN
Page 7 and 8: PRIVATE PATENTS AND PUBLIC HEALTH 3
Page 9 and 10: ANNEXES ANNEX 1 The General Council
Page 11 and 12: I dedicate this book to the memory
Page 13 and 14: INTRODUCTION PRIVATE PATENTS AND PU
Page 15 and 16: PRIVATE PATENTS AND PUBLIC HEALTH b
Page 17 and 18: PRIVATE PATENTS AND PUBLIC HEALTH g
Page 19 and 20: medicines industry to flourish in s
Page 21 and 22: PRIVATE PATENTS AND PUBLIC HEALTH M
Page 23 and 24: 12 FIGURE 1 PATENT APPLICATIONS FOR
Page 25 and 26: TIMELINE OF EVENTS RELATED TO ACCES
Page 31 and 32: 1 ENDING GLOBAL DIVERSITY IN PATENT
Page 33 and 34: PRIVATE PATENTS AND PUBLIC HEALTH v
Page 35 and 36: FIGURE 3 THE EVOLUTION IN PRICE OF
Page 37 and 38: PRIVATE PATENTS AND PUBLIC HEALTH W
Page 39 and 40: PRIVATE PATENTS AND PUBLIC HEALTH l
Page 41 and 42: PRIVATE PATENTS AND PUBLIC HEALTH c
Page 43 and 44: 2 TURNING THE TIDE: The WTO Doha De
Page 45 and 46: Paragraph 4 is often referred to as
Page 47 and 48: Parallel import or “exhaustion”
Page 49 and 50: PRIVATE PATENTS AND PUBLIC HEALTH A
Page 51 and 52: PRIVATE PATENTS AND PUBLIC HEALTH O
Page 53 and 54:
“Members may provide limited exce
Page 55 and 56:
The decisions in answer (b) could h
Page 57 and 58:
implementation to the attention of
Page 59 and 60:
BOX 7 THE TRIPS REGIONAL WAIVER The
Page 61 and 62:
3 FROM DECLARATION TO APPLICATION:
Page 63 and 64:
PRIVATE PATENTS AND PUBLIC HEALTH A
Page 65 and 66:
PRIVATE PATENTS AND PUBLIC HEALTH P
Page 67 and 68:
TABLE 1 COMPULSORY LICENSING INSTAN
Page 69 and 70:
BOX 10 COMPULSORY LICENCES IN ECUAD
Page 71 and 72:
TABLE 2 GOVERNMENT USE OF MEDICINES
Page 73 and 74:
used in the treatment of persons su
Page 75 and 76:
PRIVATE PATENTS AND PUBLIC HEALTH O
Page 77 and 78:
edundant in those countries 95 (see
Page 79 and 80:
patients with access to the four an
Page 81 and 82:
TABLE 4 RETAIL PRICE OF A DASATINIB
Page 83 and 84:
of Congress wrote to President Obam
Page 85 and 86:
PRIVATE PATENTS AND PUBLIC HEALTH w
Page 87 and 88:
PRIVATE PATENTS AND PUBLIC HEALTH b
Page 89 and 90:
PRIVATE PATENTS AND PUBLIC HEALTH M
Page 91 and 92:
TRIPS Article 1.1 indicates that it
Page 93 and 94:
PRIVATE PATENTS AND PUBLIC HEALTH p
Page 95 and 96:
PRIVATE PATENTS AND PUBLIC HEALTH w
Page 97 and 98:
defended considering the technologi
Page 99 and 100:
PRIVATE PATENTS AND PUBLIC HEALTH T
Page 101 and 102:
TABLE 7 DATA EXCLUSIVITY PROTECTION
Page 103 and 104:
PRIVATE PATENTS AND PUBLIC HEALTH h
Page 105 and 106:
aims to achieve with its patenting
Page 107 and 108:
PRIVATE PATENTS AND PUBLIC HEALTH c
Page 109 and 110:
The problem of counterfeit medicine
Page 111 and 112:
5 THE NEW FRONTIERS: Patents and tr
Page 113 and 114:
TABLE 10 SELECTED NEW MEDICINES ON
Page 115 and 116:
PRIVATE PATENTS AND PUBLIC HEALTH I
Page 117 and 118:
Health 3, No. 11: pgs. E676-e677, d
Page 119 and 120:
Cancer is a big money maker: Global
Page 121 and 122:
FIGURE 7 PRICE OF BRANDED GLIVEC VE
Page 123 and 124:
for the colorectal cancer drug Zalt
Page 125 and 126:
PRIVATE PATENTS AND PUBLIC HEALTH R
Page 127 and 128:
BOX 18 ESTABLISHING A LICENSING MEC
Page 129 and 130:
PRIVATE PATENTS AND PUBLIC HEALTH o
Page 131 and 132:
PRIVATE PATENTS AND PUBLIC HEALTH 6
Page 133 and 134:
use pooled procurement to create a
Page 135 and 136:
“[M]arket failures affected all c
Page 137 and 138:
for the Association of the British
Page 139 and 140:
A recent Access to Medicines Index
Page 141 and 142:
TABLE 18 STUDIES ON R&D COSTS OF NE
Page 143 and 144:
BOX 20 DEVELOPING A NEW INTERNATION
Page 145 and 146:
not for profit,” 335 in which the
Page 147 and 148:
PRIVATE PATENTS AND PUBLIC HEALTH a
Page 149 and 150:
It is too early to say whether the
Page 151 and 152:
ANNEXES ANNEX 1 THE GENERAL COUNCIL
Page 153 and 154:
As we have heard today, and as the
Page 155 and 156:
PRIVATE PATENTS AND PUBLIC HEALTH (
Page 157 and 158:
Page 159 and 160:
PRIVATE PATENTS AND PUBLIC HEALTH F
Page 161 and 162:
NOTES AND REFERENCES PRIVATE PATENT
Page 163 and 164:
Page 165 and 166:
PRIVATE PATENTS AND PUBLIC HEALTH d
Page 167 and 168:
PRIVATE PATENTS AND PUBLIC HEALTH I
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
PRIVATE PATENTS AND PUBLIC HEALTH (
Page 175 and 176:
Page 177 and 178:
PRIVATE PATENTS AND PUBLIC HEALTH e
Page 179 and 180:
PRIVATE PATENTS AND PUBLIC HEALTH T
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
PRIVATE PATENTS AND PUBLIC HEALTH s
Page 189 and 190:
PRIVATE PATENTS AND PUBLIC HEALTH S
Page 191 and 192:
PRIVATE PATENTS AND PUBLIC HEALTH t
Page 193 and 194:
show all

PRIVATE PATENTS AND PUBLIC HEALTH

Create successful ePaper yourself

Delete template?

Save as template?